Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemborexant for Prevention of Delirium After Cardiac Surgery (PROTEX)
NCT06648681Phase 2Not yet recruiting
- Sponsor
- University of British Columbia
- Start
- May 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lemborexant in delirium, sponsored by University of British Columbia. Planned start May 2025; status: not yet recruiting.
02
Drugs
lemborexant
03
Conditions
delirium
Beyond the preview
Go deeper on NCT06648681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06648681.